skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report

Authors:
; ; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research
OSTI Identifier:
1691986
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Transplantation Proceedings
Additional Journal Information:
Journal Name: Transplantation Proceedings Journal Volume: 52 Journal Issue: 2; Journal ID: ISSN 0041-1345
Publisher:
Elsevier
Country of Publication:
United States
Language:
English

Citation Formats

Yamane, Hiroaki, Ide, Kentaro, Tanaka, Asuka, Hashimoto, Shinji, Nagoshi, Hisao, Tahara, Hiroyuki, Ohira, Masahiro, Seidakhmetov, Akhmet, Marlen, Doskali, Tanaka, Yuka, and Ohdan, Hideki. Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report. United States: N. p., 2020. Web. https://doi.org/10.1016/j.transproceed.2019.06.006.
Yamane, Hiroaki, Ide, Kentaro, Tanaka, Asuka, Hashimoto, Shinji, Nagoshi, Hisao, Tahara, Hiroyuki, Ohira, Masahiro, Seidakhmetov, Akhmet, Marlen, Doskali, Tanaka, Yuka, & Ohdan, Hideki. Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report. United States. https://doi.org/10.1016/j.transproceed.2019.06.006
Yamane, Hiroaki, Ide, Kentaro, Tanaka, Asuka, Hashimoto, Shinji, Nagoshi, Hisao, Tahara, Hiroyuki, Ohira, Masahiro, Seidakhmetov, Akhmet, Marlen, Doskali, Tanaka, Yuka, and Ohdan, Hideki. Sun . "Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report". United States. https://doi.org/10.1016/j.transproceed.2019.06.006.
@article{osti_1691986,
title = {Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report},
author = {Yamane, Hiroaki and Ide, Kentaro and Tanaka, Asuka and Hashimoto, Shinji and Nagoshi, Hisao and Tahara, Hiroyuki and Ohira, Masahiro and Seidakhmetov, Akhmet and Marlen, Doskali and Tanaka, Yuka and Ohdan, Hideki},
abstractNote = {},
doi = {10.1016/j.transproceed.2019.06.006},
journal = {Transplantation Proceedings},
number = 2,
volume = 52,
place = {United States},
year = {2020},
month = {3}
}

Works referenced in this record:

Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant
journal, December 1999

  • Wolfe, Robert A.; Ashby, Valarie B.; Milford, Edgar L.
  • New England Journal of Medicine, Vol. 341, Issue 23
  • DOI: 10.1056/NEJM199912023412303

Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes: Systematic Review of Kidney Transplantation
journal, August 2011


Cancer Incidence Among US Medicare ESRD Patients Receiving Hemodialysis, 1996-2009
journal, May 2015

  • Butler, Anne M.; Olshan, Andrew F.; Kshirsagar, Abhijit V.
  • American Journal of Kidney Diseases, Vol. 65, Issue 5
  • DOI: 10.1053/j.ajkd.2014.12.013

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
journal, November 2011

  • Engels, Eric A.; Pfeiffer, Ruth M.; Fraumeni, Joseph F.
  • JAMA, Vol. 306, Issue 17
  • DOI: 10.1001/jama.2011.1592

Epidemiology of de novo malignancies after solid-organ transplantation: Immunosuppression, infection and other risk factors
journal, November 2014

  • Piselli, Pierluca; Verdirosi, Diana; Cimaglia, Claudia
  • Best Practice & Research Clinical Obstetrics & Gynaecology, Vol. 28, Issue 8
  • DOI: 10.1016/j.bpobgyn.2014.08.007

Myeloid Neoplasms Following Solid Organ Transplantation
journal, December 2017

  • Wu, Bin; Ingersoll, Kimberly; Jug, Rachel
  • American Journal of Clinical Pathology, Vol. 149, Issue 1
  • DOI: 10.1093/ajcp/aqx133

Risk of myeloid neoplasms after solid organ transplantation
journal, April 2014


The Biology of Chronic Myeloid Leukemia
journal, July 1999


Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
journal, April 2001


Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation
journal, March 2007

  • Thierry, A.; Dreyfus, B.; Bridoux, F.
  • Nephrology Dialysis Transplantation, Vol. 22, Issue 6
  • DOI: 10.1093/ndt/gfm052

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
journal, July 2016

  • Cortes, Jorge E.; Saglio, Giuseppe; Kantarjian, Hagop M.
  • Journal of Clinical Oncology, Vol. 34, Issue 20
  • DOI: 10.1200/JCO.2015.64.8899

Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report
journal, March 2017

  • Nakamae, Hirohisa; Fujisawa, Shin; Ogura, Michinori
  • International Journal of Hematology, Vol. 105, Issue 6
  • DOI: 10.1007/s12185-017-2208-2

Metabolism and Disposition of Dasatinib after Oral Administration to Humans
journal, April 2008

  • Christopher, Lisa J.; Cui, Donghui; Wu, Chiyuan
  • Drug Metabolism and Disposition, Vol. 36, Issue 7
  • DOI: 10.1124/dmd.107.018267

Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
journal, February 2011


Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients
journal, April 2014

  • Dhanarajan, Asha; Hsu, Jack W.; le Coutre, Philipp
  • British Journal of Haematology, Vol. 166, Issue 4
  • DOI: 10.1111/bjh.12885

Novel therapies for chronic myelogenous leukemia
journal, May 2001


Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
journal, March 2003

  • O'Brien, Stephen G.; Guilhot, François; Larson, Richard A.
  • New England Journal of Medicine, Vol. 348, Issue 11
  • DOI: 10.1056/NEJMoa022457

Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia
journal, November 2007


Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants
journal, January 2009

  • Redaelli, Sara; Piazza, Rocco; Rostagno, Roberta
  • Journal of Clinical Oncology, Vol. 27, Issue 3
  • DOI: 10.1200/JCO.2008.19.8853

New dosing schedules of dasatinib for CML and adverse event management
journal, February 2009


Renal failure associated with tyrosine kinase inhibitors—Case report and review of the literature
journal, January 2010


Kinetics of Cellular and Humoral Immunity in a Successful Case of Positive Crossmatch Kidney Transplantation: A Case Report
journal, July 2011


Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation
journal, June 2016


Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients
journal, April 2017